New Delhi, March 30 (SocialNews.XYZ) The Covid working group of National Technical Advisory on Immunisation (NTAGI) will review the data of Covovax manufactured by the Serum Institute of India (SII) this week for use in children and adults, a source said on Wednesday.
The source said that the Covid working group can meet on Friday to see if Covovax can be added to the vaccination programme for those aged 12 and above.
The subject expert committee of the Central Drugs Standard Control Organisation (CDSCO) had recently recommended granting emergency use authorisation to Covovax. On December 28 last year, the Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults.
However, the vaccine has not yet been included in the country's inoculation drive.
India started inoculating children aged 12-14 from March 16.
Meanwhile, India's vaccination coverage crossed the 184 crore landmark on Wednesday evening. As per the Health Ministry report, over 19 lakh vaccine doses were administered till 7 pm on Wednesday.
Source: IANS
About Gopi
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz